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Abstract: Amylin is co-secreted with insulin by pancreatic ฀-cells in response to a meal and produced by
neurons in discrete hypothalamic brain areas. Leptin is proportionally secreted by the adipose tissue.
Both hormones control food intake and energy homeostasis post-weaning in rodents. While amylin’s main
site of action is located in the area postrema (AP) and leptin’s is located in the mediobasal hypothala-
mus, both hormones can also influence the other’s signaling pathway; amylin has been shown enhance
hypothalamic leptin signaling, and amylin signaling in the AP may rely on functional leptin receptors to
modulate its effects. These two hormones also play major roles during other life periods. During preg-
nancy, leptin levels rise as a result of an increase in fat depot resulting in gestational leptin-resistance to
prepare the maternal body for the metabolic needs during fetal development. The role of amylin is far
less studied during pregnancy and lactation, though amylin levels seem to be elevated during pregnancy
relative to insulin. Whether amylin and leptin interact during pregnancy and lactation remains to be
assessed. Lastly, during brain development, amylin and leptin are major regulators of cell birth during
embryogenesis and act as neurotrophic factors in the neonatal period. This review will highlight the role
of amylin and leptin, and their possible interaction, during these dynamic time periods of pregnancy,
lactation, and early development.
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78 Abstract—Amylin is co-secreted with insulin by pancreatic b-cells in response to a meal and neurons in discrete
hypothalamic brain areas have been shown to produce amylin. Leptin is proportionally secreted by the adipose
tissue. Both hormones control food intake and energy homeostasis post-weaning in rodents. While amylin’s main
site of action is located in the area postrema (AP) and leptin’s is located in the mediobasal hypothalamus, both
hormones can also influence the other’s signaling pathway; amylin has been shown enhance hypothalamic leptin
signaling and amylin signaling in the AP may rely on functional leptin receptors to modulate its effect. These two
hormones also play major roles during other life periods. During pregnancy, leptin levels rise as a result of an
increase in fat depot resulting in gestational leptin-resistance to prepare the body for the metabolic needs during
the fetal development. Leptin levels decrease rapidly during the post-partum period and remaining elevated levels
could predispose to post-partum depression. The role of amylin is far less studied during pregnancy and
lactation, and amylin levels seem to be elevated during pregnancy relative to insulin. Whether amylin and leptin
interact during pregnancy and lactation remains to be assessed. Last, during brain development, amylin and
leptin are major regulators of cell birth during embryogenesis and act as neurotrophic factors in the neonatal per-
iod. This review will highlight the role of amylin and leptin during these different time periods.  2019 IBRO. Pub-
lished by Elsevier Ltd. All rights reserved.
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9 GENERAL INTRODUCTION
10 Pregnancy, lactation, and the early postnatal period
11 represent life phases of rapid growth and hormonal
12 fluxes. While classically viewed as satiating and
13 adiposity factors, the pancreatic hormone amylin and
14the adipokine leptin are also key players orchestrating
15changes in the brain and body during these three
16phases. In this review, we will first summarize the
17basics of amylin and leptin production and signaling,
18and how and when these hormones interact. We will
19then explore recently published and newly hypothesized
20ways that these hormones cooperate to control
21physiology, behavior and changes in the brain during
22the dynamic periods of pregnancy, lactation, and
23postnatal development.
24AMYLIN-LEPTIN INTERACTION AND
25HYPOTHETICAL MECHANISM OF ACTION IN
26THE CAUDAL HINDBRAIN AND MEDIOBASAL
27HYPOTHALAMUS
28Amylin action, receptors and signaling
29Amylin is a 37-amino acid, approximately 4 kDa peptide
30hormone co-synthetized and co-secreted with insulin by
31pancreatic b-cells in response to a meal intake (Ogawa
32et al., 1990). Amylin is a short-acting peptide with a
3315 min half-life (Young, 2005) and binds to heterodimeric
34receptors composed of the calcitonin receptor (CTR) a or
35b and one of the three receptor activity modifying protein
36(RAMP) 1–3 (Qi et al., 2008; Lee et al., 2016). Together
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Abbreviations: AgRP, agouti-related peptide; AMY, amylin receptor;
AP, area postrema; ARC, arcuate nucleus of the hypothalamus; BBB,
blood–brain barrier; CTR, calcitonin receptor; DiI, 1,10-dioctadecyl-3,3
,30,30-tetramethylindocarbocyanine perchlorate; DIO, diet-induced
obese; DMN, dorsal medial nucleus of the hypothalamus; DR, diet-
resistant; ERK/MAPK, extracellular-signal-regulated kinase/Mitogen-
activated protein kinase; GDM, gestational diabetes mellitus; HFD,
high fat diet; hIAPP, human islet amyloid polypeptide (amylin); IBAT,
interscapular brown adipose tissue; IL-6, interleukin-6; LDTg, lateral
dorsal tegmental nucleus; Lepr-b, leptin receptor b; LH, lateral
hypothalamus; LPBN, lateral parabrachial nucleus; MC4 receptor,
melanocortin-4-receptor; NPY, neuropeptide Y; NTS, nucleus of the
solitary tract; PI3K, phosphoinositide-3 kinase; POA, preoptic area;
POMC, pro-opiomelanocortin; pSTAT3, phosphorylated signal
transducer and activator of transcription 3; PVN, paraventricular
nucleus of the hypothalamus; RAMP, receptor activity modifying
protein; TIP39, tuberoinfundibular peptide of 39 residues; VMH,
ventral medial hypothalamus (ARC + VMN); VMN, ventral medial
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37 CTR and RAMP can form 3 different amylin receptors
38 subtypes AMY1-3 (Hay et al., 2015). RAMP increases
39 the affinity of amylin to CTR (Tilakaratne et al., 2000).
40 Using 125I amylin, amylin receptor binding sites have been
41 detected in the area postrema (AP), in the hypothalamus,
42 such as in the arcuate nucleus (ARC), ventromedial
43 nucleus (VMN) and dorsomedial nucleus (DMN) of the
44 hypothalamus, as well as in the ventral tegmental area
45 (VTA) and lateral dorsal tegmental nucleus (LDTg)
46 (Sexton et al., 1994; van Rossum et al., 1994; Hilton
47 et al., 1995; Reiner et al., 2017). Studies using AP lesion
48 and pharmacological approaches have revealed that the
49 AP is peripheral amylin’s primary site of action by which
50 it decreases food intake by promoting meal termination
51 (Lutz et al., 2001; Riediger et al., 2001; Riediger et al.,
52 2004). AP amylin-activated neurons project their signal
53 onto the lateral parabrachial nucleus (LPBN), which pro-
54 jects to the central amygdala (Braegger et al., 2014;
55 Potes and Lutz, 2010; Potes et al., 2010b,a). Calcitonin
56 gene-related peptide (CGRP) LPBN neurons are directly
57 innervated by hypothalamic agouti-related peptide
58 (AgRP) neurons (Essner et al., 2017) and respond to
59 direct or indirect amylin activation by decreasing food
60 intake (Carter et al., 2013). At the single cell level in the
61 AP, CTRa seems to be the main subunit present and
62 CTRa + cells are colocalized with RAMP1 and/or
63 RAMP3 (Liberini et al., 2016b). In order to act in nuclei
64 other than in circumventricular organs, such as the AP,
65 amylin has been hypothesized to cross the blood–brain
66 barrier (BBB) (Banks and Kastin, 1998; Banks et al.,
67 1995). In the mediobasal hypothalamus, we have shown
68 using multiple animal models that amylin can directly acti-
69 vate pERK signaling in pro-opiomelanocortin (POMC)
70 neurons (Lutz et al., 2018). While during the neonatal per-
71 iod, amylin activates pERK in POMC neurons to enhance
72 a-MSH fiber projections from the ARC? PVN (Lutz et al.,
73 2018), the physiological role of this activation in adult
74 rodents is currently under investigation and our current
75 hypothesis is that amylin-induced pERK in POMC neu-
76 rons is involved in the regulation of energy expenditure.
77 In other nuclei, such as the VTA, amylin modulates food
78 palatability by favoring fat intake over sucrose intake
79 (Mietlicki-Baase et al., 2017). In the LDTg, injection of
80 amylin or its receptor agonist, salmon calcitonin,
81 decreases body weight, food intake, meal size and moti-
82 vated feeding (Reiner et al., 2017).
83 Leptin action, receptors and signaling
84 Leptin is a 16 kDa protein hormone that, under weight
85 stable conditions (Gloy et al., 2010), is produced by the
86 adipose tissue proportional to adipose tissue mass and
87 released into the blood stream. Leptin is then transported
88 across the BBB (Bjorbaek et al., 1997; Balland et al.,
89 2014) and acts on leptin receptor b isoform (Lepr-b),
90 which is expressed in neurons in a distributed network
91 throughout the brain (Banks et al., 1996; Caron et al.,
92 2010; Balland et al., 2014). These leptin-sensitive neu-
93 rons are located in ARC, VMN, DMN, paraventricular
94 nucleus of the hypothalamus (PVN), lateral hypothalamus
95 (LH), preoptic area (POA), VTA and AP/nucleus of the
96 solitary tract (NTS) (Figlewicz, 2016; Friedman, 2016;
97Ghamari-Langroudi et al., 2011; Godfrey and Borgland,
982019). Binding of leptin to Lepr-b leads to the recruitment
99and autophosphorylation of Janus-Activated Kinase 2
100(JAK2) and the subsequent phosphorylation of intracellu-
101lar tyrosine residues (Vaisse et al., 1996; Bjorbaek et al.,
1021997). Once phosphorylated, pSTAT3 then dimerizes and
103translocates into the nucleus to regulate gene transcrip-
104tion (Pan et al., 2019). pSTAT3 is a surrogate for JAK/
105STAT3 pathway activation. In addition to the JAK/STAT3
106signaling pathway, there are also two additional down-
107stream signaling pathways activated by leptin:
108phosphoinositide-3 kinase (PI3K) and extracellular-factor
109regulated kinase (ERK) – mitogen-activated protein
110kinase (MAPK; ERK-MAPK) (Bjorbaek et al., 2001;
111Niswender et al., 2001). Activation of Lepr-b leads to a
112number of metabolic processes; pSTAT3 activation in
113POMC and AgRP/neuropeptide Y (NPY) neurons in the
114ARC decreases food intake, while PI3K pathway is
115involved in cell growth, proliferation and death (Chang
116and Karin, 2001; Vanhaesebroeck et al., 2012). Impor-
117tantly, in the rodent, leptin functions as a neurotrophic fac-
118tor during the pre-weaning period (see paragraph below),
119whereas after pathway formation is complete (post-
120weaning), leptin serves to regulate energy homeostasis.
121Synergistic interaction between amylin and leptin
122Interaction in the hypothalamus. More than 10 years
123ago, Roth et al. were the first to report that amylin
124restored leptin responsiveness in diet induced obese
125(DIO) rats and obese humans (Roth et al., 2008;
126Trevaskis et al., 2008). Together amylin and leptin
127induced a greater decrease in body weight, food intake
128and fat deposition, as well as an increase in energy
129expenditure, than amylin or leptin alone. In obese rats,
130amylin pretreatment partially restored leptin-induced
131pSTAT3 in the VMN but not in the ARC (Roth et al.,
1322008). In lean rats, amylin and leptin synergistically acti-
133vated pSTAT3 and increased leptin binding in the ARC
134and VMN (Turek et al., 2010). The crucial role of amylin
135in enhancing leptin signaling was further confirmed using
136amylin KO mice whereby leptin induced-pSTAT3 and lep-
137tin’s lowering effect on body weight were attenuated
138(Turek et al., 2010). Peripheral amylin injection also
139increased POMC mRNA expression in rats (Roth et al.,
1402006) and inhibition of the melanocortin 4 receptor pre-
141vented amylin-induced inhibition of feeding and the
142increase of interscapular brown adipose tissue (iBAT)-
143induced thermogenesis (Li et al., 2019). These results
144suggest a central role of POMC neurons in mediating
145amylin’s actions but whether leptin is also involved in
146enhancing these effects remains to be determined.
147To uncover the mechanism by which amylin is able to
148enhance leptin signaling, primary neuron, astrocyte and
149microglial cell culture were exposed to amylin and
150among all cytokines, interleukin-6 (IL-6) production was
151increased in microglia only. The role of IL-6 in mediating
152amylin’s action was confirmed by injecting anti-IL-6
153antibody in the third ventricle to neutralize endogenously
154produced IL-6. This intervention completely inhibited
155amylin’s enhancing effect on leptin-induced pSTAT3 in
2 C. N. Boyle, C. Le Foll / Neuroscience xxx (2019) xxx–xxx
NSC 19393 No. of Pages 12
18 December 2019
Please cite this article in press as: Boyle CN, Le Foll C. Amylin and Leptin interaction: Role During Pregnancy, Lactation and Neonatal Development. Neuroscience (2019), https://doi.org/10.1016/j.
neuroscience.2019.11.034
156 the VMN in rats (Le Foll et al., 2015). The exposure of pri-
157 mary neurons to IL-6 for 4 days increased Lepr-b mRNA
158 expression and using Ca2+ imaging, it restored the
159 responsiveness to leptin of primary neurons harvested
160 from leptin-resistant DIO rats (Larsen et al., 2016). Thus,
161 we hypothesized that amylin acts on microglia to produce
162 IL-6 which then binds to its neuronal receptor that is com-
163 posed of gp130. IL-6 activated gp130 is then able to co-
164 activate pSTAT3 with leptin (Le Foll et al., 2015). Follow-
165 ing the depletion of the CTR subunit of the amylin recep-
166 tor heterodimer in the ventromedial hypothalamus
167 (VMH= ARC+ VMN) using an AAV CTR shRNA, diet-
168 resistant (DR) rats, which display normal leptin signaling,
169 have reduced ARC and VMN 125I leptin binding and leptin-
170 induced pSTAT3 (Dunn-Meynell et al., 2016). CTR VMH
171 depletion increased body weight, food intake and fat pads
172 in chow and high fat diet (HFD)-fed DR rats as compared
173 to scrambled-AAV injected controls. Thus, endogenous
174 amylin signaling is necessary for the maintenance of
175 energy homeostasis and is required for full leptin signaling
176 (Dunn-Meynell et al., 2016). More recently, the depletion
177 of Lepr-b in CTR neurons in mice drastically increased
178 food intake leading to an obese phenotype without alter-
179 ing glucose tolerance (Pan et al., 2018). The transcrip-
180 tomic analysis of CTR+ neurons in the WT and
181 depleted mice revealed that AgRP and NPY mRNA were
182 highly enriched in the hypothalamus whereas POMC was
183 also detected but at a much lower level (Campbell et al.,
184 2017; Pan et al., 2018).
185 Interaction at the level of AP. Several pieces of recent
186 evidence support the notion that amylin and leptin not only
187 interact at the level of the hindbrain, but might also form
188 an interdependent relationship, expanding on the initial
189 observations that amylin unidirectionally potentiates
190 leptin action. Db/db mice, which lack functional leptin
191 receptors, have a reduced anorectic response to amylin,
192 do not mount an amylin-induced Fos response in the
193 AP, and have reduced CTR density in the AP (Duffy
194 et al., 2018). Single-cell analysis of amylin-activated AP
195 neurons demonstrated that such neurons not only
196 express all amylin receptor components (CTR and
197 RAMPs), but also Lepr-b mRNA (Liberini et al., 2016b).
198 Amylin and leptin were also shown to depolarize the same
199 dissociated AP neurons (Smith et al., 2016). Together
200 these data suggest that amylin and leptin might target
201 the same population of first-order neurons in the AP,
202 and that co-activation of these neurons is required for
203 amylin to induce changes in ingestive behavior and accu-
204 mulation of Fos protein in AP neurons.
205 Limitations of the interaction. The key to
206 understanding the mechanism of amylin and leptin’s
207 interaction may lie within the limitations of this synergy.
208 Cumulating evidence suggests that a certain level of
209 leptin signaling is necessary for amylin to promote leptin
210 sensitivity. For example, extremely obese rats do not
211 exhibit amylin-induced leptin sensitivity, though they are
212 still responsive to amylin alone (Trevaskis et al., 2010;
213 Trevaskis et al., 2016). Even after significant weight loss
214 by calorie restriction, the once obese rats show no further
215reduction in body weight when amylin and leptin are given
216together (Trevaskis et al., 2016); the authors proposed
217that neither leptin alone nor in combination with amylin
218could overcome the strong orexigenic drive produced by
219prolonged caloric restriction. We, in fact, previously
220observed this phenomenon, when rats restricted to 80%
221of ad libitum food intake were non-responsive to amylin’s
222satiating effect (Boyle et al., 2011). Together these obser-
223vations suggest that amylin’s action to induce satiation or
224potentiate leptin signaling is least effective in instances of
225absent or low leptin signaling, such as genetic leptin- or
226Lepr-deficiency, extreme obesity, or following chronic
227food restriction (Boyle and Lutz, 2011; Boyle et al.,
2282011; Eiden et al., 2002; Trevaskis et al., 2016).
229LEPTIN AND AMYLIN’S INTERACTION DURING
230PREGNANCY AND LACTATION
231Changes in leptin sensitivity during pregnancy and
232lactation
233Pregnancy and lactation are two metabolically dynamic
234periods of a female’s life when both the levels of and
235receptivity to sex and metabolic hormones are changing
236rapidly. The first and second trimesters of human
237pregnancy are characterized as anabolic, during which
238the body prepares for the metabolic demands of late
239pregnancy and lactation by increasing maternal fat
240deposition (Villar et al., 1992). Pregnant women exhibit
241hyperphagia, insulin resistance and hyperinsulinemia,
242and mild hyperglycemia to ensure transfer of nutrients
243to the growing fetus (Zeng et al., 2017). From the third tri-
244mester, a switch to a catabolic state accelerates the
245breakdown of fat depots, mobilizing the energy substrates
246required for late stages of fetal development and lactation
247(Knopp et al., 1970; Herrera, 2000).
248A natural consequence of increased fat deposition
249during pregnancy is the rise in circulating leptin. In
250pregnant women and female rats, leptin levels rise
251during the first and second trimesters and peak in the
252late second or early third trimester (Hardie et al., 1997;
253Seeber et al., 2002). Under non-pregnant conditions,
254such an increase in leptin would signal the brain to reduce
255food intake and increase energy expenditure. During
256pregnancy, however, a state of leptin resistance develops
257to further promote maternal hyperphagia and weight gain,
258which are essential for fetal growth and development.
259Ladyman, Grattan and colleagues have extensively char-
260acterized the time course and mechanisms underlying the
261development of leptin resistance in pregnant rat and
262mouse dams (Reviewed in Ladyman et al., 2010). A
263rodent pregnancy can last from 21 to 23 days, and though
264still responsive to exogenous leptin on gestational day 7,
265rat dams do not reduce their food intake on gestational
266day 14, suggesting a state of leptin insensitivity
267(Ladyman and Grattan, 2004). Their data suggest that
268several factors contribute to gestational leptin resistance,
269including reduced STAT3 activation in first-order ARC and
270VMN neurons (Ladyman and Grattan, 2004), reduced
271Lepr-b expression in the VMN (Ladyman and Grattan,
2722005), reduced responsiveness of the downstream mela-
273nocortin system in both first-order and second-order
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274 nuclei, such as the PVN (Ladyman et al., 2009, 2016),
275 and possibly reduced transport of leptin into the brain.
276 Unlike in obesity-induced leptin resistance, however,
277 these modifications are not thought to be caused by ges-
278 tational hyperleptinemia per se (Augustine et al., 2019).
279 This notion is supported by the fact that gestational leptin
280 levels are typically lower than the leptin levels required to
281 induce leptin resistance, and that gestational leptin resis-
282 tance occurs close to the same time as when leptin levels
283 are significantly increasing, suggesting that leptin resis-
284 tance occurs in parallel to rising leptin levels, rather than
285 being a consequence of them (Augustine et al., 2019;
286 Ladyman and Grattan, 2004).
287 Twenty-four hours after delivery, leptin levels
288 dramatically fall below the level of non-pregnant control
289 women, and then progressively increase during the next
290 6 postpartum months (Lage et al., 1999). As this rapid, ini-
291 tial drop in leptin occurs before the reduction of maternal
292 fat depots, it is likely that this drop reflects the loss of the
293 placenta, which is also a primary source of leptin during
294 pregnancy (Masuzaki et al., 1997). A recent study
295 showed an interesting association between leptin levels
296 in the first 48 h postpartum and risk for postpartum
297 depression. Chinese women reporting depressive symp-
298 toms at 3 months postpartum had significantly higher lep-
299 tin levels, as well as BMI (Chen et al., 2016), suggesting
300 that early postpartum leptin levels could be used as a bio-
301 marker to predict risk of developing postpartum depres-
302 sion. The time course of regaining central leptin
303 sensitivity following birth has not been exhaustively stud-
304 ied, however, one studied showed that 9 weeks after
305 weaning pups, mouse dams exhibit both an anorectic
306 response and increased hypothalamic pSTAT3 following
307 leptin treatment that are similar to the effects observed
308 in virgin female mice (Ladyman et al., 2018).
309 Role of pancreatic amylin during pregnancy and
310 lactation
311 Whether the metabolic actions of amylin change during
312 pregnancy is far less investigated than leptin. Though
313 fasting plasma amylin levels were not different, it was
314 shown that pregnant women have elevated amylin in
315 response to an oral glucose load compared to non-
316 pregnant women (Kautzky-Willer et al., 1997). Whether
317 the pregnant women were normal glucose tolerant or
318 had gestational diabetes mellitus (GDM) did not further
319 influence these elevated amylin levels. Pregnancy also
320 resulted in an increase in the amylin-to-insulin co-
321 secretion factor (Kautzky-Willer et al., 1997); the authors
322 hypothesized that increased amylin secretion relative to
323 insulin might counteract the effects of gestational hyperin-
324 sulinemia, thus acting as a safeguard against hypogly-
325 caemia, but it should be noted that the physiological or
326 pathophysiological relevance of altered amylin-to-insulin
327 ratio is generally unknown. Amylin was also observed in
328 human and rat placenta, and its expression was
329 decreased by food restriction, suggesting a potential role
330 for amylin in placental metabolic function (Caminos et al.,
331 2009).
332 While we know that circulating amylin levels are
333 elevated during pregnancy, similar to leptin, it was not
334previously investigated whether hyperamylinemia also
335results in reduced amylin sensitivity. According to the
336hypothesis put forth by Krautzky-Willer and colleagues,
337increased amylin might serve as an important protective
338mechanism against hypoglycemia in the face of
339gestational hyperinsulinemia, so unlike leptin, a
340reduction in amylin sensitivity would be
341counterproductive. In fact, we have recently observed
342that during mid-gestation, rat dams treated with acute
343exogenous amylin reduce their food intake to
344approximately 40% of their baseline food intake
345(unpublished observations), which is consistent with the
346satiating effect observed in healthy male rats (Braegger
347et al., 2014; Duffy et al., 2018). Preserved amylin-
348induced satiation during pregnancy suggests that loss of
349amylin sensitivity does not contribute to gestational hyper-
350phagia. These data are also consistent with our previous
351work showing that, again unlike leptin, hyperamylinemia is
352not equated with amylin resistance—both obese male rats
353maintained on HFD, and lean rats made hyperamylinemic
354via chronic amylin infusion still reduced food intake in
355response to acute peripheral treatment with amylin
356(Boyle et al., 2011).
357Peripheral amylin levels appear to decrease in the
358postpartum period. There are data showing that amylin
359returns to pre-partum levels 12–16 weeks after delivery
360in both healthy women and those diagnosed with GDM
361(Kautzky-Willer et al., 1997). However, another study
362showed that fasting amylin levels were twofold higher in
363women diagnosed with GDM than in healthy controls at
3646 weeks postpartum (Kinalski et al., 2004). It is presently
365unclear whether these differential effects are merely
366related to the time of amylin measurement, or if elevated
367early postpartum amylin levels might actually be indicative
368of metabolic disruption (Kinalski et al., 2004). A recent
369study demonstrated that mice transgenic for human amy-
370lin (hIAPP mice) are prone to developing diabetes during
371and after pregnancy resulting from beta cell stress (Gurlo
372et al., 2019). While rodent amylin is soluble and non-
373aggregating (Huang et al., 2007), human and cat amylin
374is amyloidogenic, forming toxic oligomers that eventually
375cause beta cell destruction and are present in type 2 dia-
376betes. Rodents typically do not develop gestational dia-
377betes that is comparable to the human condition (Plows
378et al., 2017), however hIAPP mice present a useful model
379of beta cell dysfunction that recapitulates several charac-
380teristics of human GDM (Gurlo et al., 2019). Whether
381increased expression of amylin or the formation of cyto-
382toxic amyloid deposits in pancreatic beta cells contributes
383to human cases of GDM has not been determined (Gurlo
384et al., 2019).
385Role of central amylin during lactation
386Interestingly, Dobolyi and colleagues showed that in
387postpartum rat dams, amylin expression in the brain is
388remarkably upregulated in the POA of the hypothalamus
389(Dobolyi, 2009; Szabo et al., 2012), a critical center for
390the initiation and maintenance of maternal behavior. Amy-
391lin levels do not increase until day 1 postpartum, and
392remain elevated up until day 23, when their pups were
393weaned (Szabo et al., 2012). Whether and at what rate
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394 amylin levels in this brain area are reduced after weaning
395 was not studied. If mother rats are deprived of their pups
396 following birth, amylin levels in the POA are similar to
397 those observed in virgin female rats (Dobolyi, 2009). Nul-
398 liparous rats that were maternally sensitized, however,
399 also exhibited increased amylin mRNA, demonstrating
400 the importance of pup exposure to this change in central
401 amylin levels (Szabo et al., 2012). This idea was further
402 confirmed by data showing that approximately 85% of
403 amylin-producing neurons in the POA co-express Fos in
404 response to pup exposure (Szabo et al., 2012).
405 The driver behind this significant increase in amylin
406 production in the maternal brain has not been
407 completely determined. Ovariectomy of virgin rats does
408 not lead to induction of amylin in the POA, suggesting
409 that reduced levels of ovarian hormones themselves (as
410 occurs at the time of parturition) do not drive the
411 increase in amylin per se (Szabo et al., 2012). However,
412 since the hormonal status of a newly primiparous female
413 and an ovariectomized virgin female rat are not identical,
414 excluding a role of sex hormones in postpartum amylin
415 production is perhaps premature. Dobolyi and colleagues
416 have proposed that the tuberoinfundibular peptide of 39
417 residues (TIP39) could be a regulator of amylin expres-
418 sion levels. TIP39-producing neurons in the posterior
419 intralaminar complex of the thalamus are activated by
420 pup suckling (Cservenak et al., 2010) and may contribute
421 to suckling-induced prolactin release (Cservenak et al.,
422 2013). These neurons send fibers to numerous hypotha-
423 lamic nuclei, including the POA (Dobolyi et al., 2003;
424 Dobolyi, 2011), which expresses postpartum amylin. In
425 addition to the amylin-expressing cells in the POA
426 described by Dobolyi, we have also observed amylin
427 immunoreactivity in the subfornical organ, supraoptic
428 nucleus, and ARC of lactating rat dams (unpublished
429 observations). The expression pattern of hypothalamic
430 amylin-producing cells is notably similar to that of
431 prolactin-sensitive cells (Brown et al., 2010; Kamesh
432 et al., 2018). Whether the increase in central amylin
433 expression is related to the increasing prolactin levels,
434 which peak at the time of birth and in response to suckling
435 stimuli, has not been investigated.
436 Do amylin and leptin interact during pregnancy and
437 lactation?
438 To date, the presence of an interaction between leptin
439 and amylin during pregnancy and lactation has not been
440 directly investigated. Unlike leptin resistance that results
441 from obesity, gestational leptin resistance is an
442 important adaptation to ensure the health of the growing
443 fetus. Thus amylin’s potential to restore leptin sensitivity
444 would potentially be disadvantageous in this condition.
445 Interestingly, IL-6 mRNA levels are reduced in the
446 hypothalamus of pregnant mice (Pazos et al., 2013).
447 Given that amylin enhances leptin signaling by increasing
448 hypothalamic IL-6 (Le Foll et al., 2015), a reduction of IL-6
449 during pregnancy could hypothetically prevent amylin
450 from enhancing central leptin signaling, thus maintaining
451 gestational leptin resistance.
452 Could alterations in leptin levels and sensitivity also
453 influence central amylin levels in postpartum dams?
454Given the huge surge of brain amylin following
455parturition, perhaps this is related to a leptin insensitive
456pregnant brain transitioning into a postpartum brain,
457which is regaining leptin sensitivity? Data from Li and
458colleagues, demonstrating that leptin levels appear to
459influence central amylin expression in non-pregnant
460female and male mice, provide additional insight into
461what is regulating these amylin-producing neurons in the
462brain (Li et al., 2015). Messenger RNA levels of hypotha-
463lamic amylin were higher in female mice than in males.
464Female ob/ob mice, which do not produce leptin and are
465subsequently obese, had significantly reduced hypothala-
466mic amylin mRNA compared to wild type females, but
467expressed levels similar to those observed in male wild
468type and ob/ob mice. When treated with exogenous leptin
469for three months, ob/ob female mice, but not males,
470showed elevated levels of hypothalamic amylin mRNA.
471In DIO mice maintained on HFD for 26 weeks, in which
472leptin levels are high but leptin sensitivity is low, central
473amylin expression was decreased in females, but ele-
474vated in males. These data suggest that leptin and leptin
475sensitivity, and potentially female sex hormones, may be
476critical factors regulating centrally produced amylin. Estro-
477gens are indeed protective against various genetic modi-
478fications that promote metabolic disease states, including
479Lepr deficiency (Mauvais-Jarvis et al., 2017). And while a
480genetic mutation such as leptin deficiency has clear con-
481sequences for central amylin production (Li et al., 2015), it
482is unknown if a polygenic predisposition for obesity would
483also influence central amylin expression. Do leptin-
484resistant DIO and leptin-sensitive DR rats exhibit inherent
485differences in central amylin during lactation? Do differ-
486ences in central amylin expression dictate the quality of
487maternal care that a dam provides her pups? Does lacta-
488tion intensity contribute to central amylin expression? Are
489differences in central amylin a consequence of or contrib-
490utors to varying levels of leptin responsiveness? Addi-
491tional questions, like whether postpartum central amylin
492levels are altered by maternal leptin levels, obesity or con-
493sumption of HFD during pregnancy or lactation, are cur-
494rently being explored.
495AMYLIN AND LEPTIN INTERACTION DURING
496DEVELOPMENT
497Brain development involves neuronal birth or
498neurogenesis that is then followed by the migration of
499these neurons to their target nuclei and finally by the
500formation of neuronal circuits which involve axonal
501outgrowth and synaptogenesis (Markakis, 2002; Bouret,
5022010a). Amylin and leptin have been shown to modulate
503these processes (Bouret, 2010b; Johnson et al., 2016;
504Lutz et al., 2018).
505Neurogenesis in brain areas involved in the control of
506energy metabolism
507During embryogenesis. Cells in the mediobasal
508hypothalamus are born between embryonic day (E) 11
509and E16 (Ishii and Bouret, 2012; Padilla et al., 2010) with
510a peak at E12 (Croizier et al., 2010). In the ARC, most of
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511 the POMC neurons are born between E12-E14 whereas
512 NPY neurons are first detected at E13.5 (Padilla et al.,
513 2010). In the caudal hindbrain, where the AP is located,
514 cell birth during embryogenesis and particularly the role
515 of the different hormones, has been far less studied. How-
516 ever PHOX2B, a transcription factor that is required for
517 the development of the autonomic nervous system and
518 the birth of noradrenergic neurons, a population onto
519 which amylin signals (Braegger et al., 2014), is already
520 expressed at E14.5 (Gokozan et al., 2016). Furthermore
521 the expression of CTR has been found at E12/13 in the
522 POA, hypothalamus, anterior and posterior pons as well
523 as in the medulla regions (Tolcos et al., 2003). Amylin
524 has also been first detected in pancreatic islet at E12
525 where its secretion seems to reach a peak at E17 during
526 the fetal period (Rindi et al., 1991; Mulder et al., 1998).
527 Together these data suggest that amylin and its receptor
528 are present embryonically starting at least at E12.
529 We recently investigated the role of endogenous
530 amylin during embryonic development (Lutz and Le Foll,
531 2019). Pregnant amylin KO and WT littermate mice were
532 injected with BrdU, a thymidine analog and marker of
533 newly born cells, at E11.5-E12, i.e. the time when amylin
534 has been shown to be secreted and when cells are born in
535 the hypothalamus and in the hindbrain. The quantification
536 of BrdU+ cells in the offspring at postnatal day (P) 2
537 showed that newborn amylin KO mice have less cells
538 being born in the ARC at E11.5-E12. Interestingly, among
539 the cells being born, the same number of neurons was
540 found in WT and KO, however less microglial cells were
541 born in KO mice compared to WT. Meanwhile in the
542 VMN, DMN, LH and AP, the number of newly born cells
543 was similar in WT and KO, but, among those cells, less
544 microglia cells were born in the AP of KO mice (Lutz
545 and Le Foll, 2019). Thus, during brain development
546 between day E12 and P2, amylin does not appear to play
547 a role in neurogenesis processes, but it contributes to the
548 birth and the fate of microglial cells in the ARC and AP.
549 Since microglial cells originate from erythrocyte precur-
550 sors in the yolk sac and migrate to the brain during
551 embryogenesis at E9.5 (Ginhoux et al., 2010; Sousa
552 et al., 2017), whether peripheral amylin affects the migra-
553 tion of these cells to the brain should also be investigated.
554 Leptin is one of the most studied protein hormones in
555 the context of obesity and the role of metabolic signals in
556 brain development. Even though the mouse embryo
557 presents a very low amount of white adipose tissue,
558 leptin has been measured in mice embryo starting at
559 E14 (Udagawa et al., 2006). Further, it has also been
560 shown that maternal leptin cannot cross the placental bar-
561 rier (Udagawa et al., 2006), suggesting that leptin pro-
562 duced by the fetus is involved in neurogenesis
563 processes. Lepr-b mRNA has been detected at E12 in
564 the hindbrain and the hypothalamus, with its expression
565 level increasing by 5–10-fold at E14 (Croizier et al.,
566 2016). Further, Lepr-b positive cells are co-expressed
567 with nestin, a neuronal marker, at E14 in mice cerebral
568 cortex (Udagawa et al., 2006). To study the role of leptin
569 in embryonic brain development, WT mice, injected with
570 BrdU from E11 to E18, were treated with leptin at
571 8 weeks-old and leptin-induced c-Fos was assessed and
572co-labelled with BrdU+ cells to measure the number of
573neurons responding to leptin that were born between
574E11 and E18. Mice that were injected at E12 with BrdU
575presented the highest number of cells positive for both
576BrdU and leptin-induced c-Fos in ARC, VMN, DMN and
577LH (Ishii and Bouret, 2012), confirming that E12 is a crit-
578ical time point during which most of the leptin-sensitive
579neurons are being born. These findings provide a plausi-
580ble explanation for an observation made more than
58140 years ago showing that ob/ob mice displayed a smaller
582brain (weight and volume) compared to WT mice (Bereiter
583and Jeanrenaud, 1979) and that ob/ob mice presented a
584mild hypocellularity in the ARC and VMN (Garris, 1989).
585When BrdU was injected between E14 and E16, the num-
586ber of BrdU+ cell in the neuroepithelium in the cortex was
587reduced in ob/ob mice compared to WT mice; this reduc-
588tion was prevented when leptin was injected directly into
589the mice embryos lateral ventricle, further demonstrating
590the critical role of leptin during embryogenesis
591(Udagawa et al., 2006). Unfortunately, ob/ob mice neuro-
592genesis was never assessed in other brain areas.
593Based on the known interaction between amylin and
594leptin in adult animals, and the fact that amylin and
595leptin seem to both contribute to cell birth at E2 (Ishii
596and Bouret, 2012; Lutz and Le Foll, 2019), we sought to
597determine if amylin influences the birth of cells that are
598leptin sensitive. WT and amylin KO mice injected with
599BrDU at E12 were assessed for leptin-induced c-Fos at
6005 weeks old in in ARC, VMN, LH and DMN. These nuclei
601have been shown to be sensitive to leptin’s action on food
602intake and energy homeostasis (Bouret, 2017; Park and
603Ahima, 2015). The same number of BrdU+ leptin-
604sensitive cells were quantified in ARC and DMN while in
605the VMN and LH, amylin KO mice displayed a higher
606number of BrdU+ leptin-sensitive cells (Lutz and Le
607Foll, 2019). Interestingly, the absence of amylin did not
608decrease the birth of leptin-sensitive cells in the hypotha-
609lamus. On the contrary, the absence of amylin even
610increased the number of leptin-sensitive cells in the
611VMH and LH suggesting a possible counter-regulatory
612mechanism. To fully assess amylin’s neurogenic role,
613future studies examining amylin KO and WT littermates
614at earlier and later time-points need to be undertaken.
615Furthermore, the assessment of apoptosis in these stud-
616ies was not performed and even though amylin does not
617affect the number of newly born neurons when assessed
618at P2 and 5 weeks old, it is possible that cell death was
619affected and that the overall balance cell birth/death is
620modulated by amylin during embryogenesis (Dekkers
621et al., 2013).
622At adulthood. Neurogenesis is not limited to the
623embryonic period but proceeds throughout the entire
624lifespan in the dentate gyrus of the hippocampus and
625the olfactory bulb (Duman et al., 2001a,b; Lledo and
626Valley, 2016). New evidence indicates that hormones
627such as amylin, leptin, insulin and ghrelin may also
628enhance adult neurogenesis in different brain areas
629(Liberini et al., 2016a; Bouret, 2017). The purpose and
630functional relevance of this adult neurogenesis is still
631under investigation, but since the brain does not grow in
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632 size, this process could be part of a renewing mechanism
633 that is probably activated by these hormones. Whether
634 these hormones could change or improve the metabolic
635 characteristics of the newly born cells remain to be
636 determined.
637 A BrdU pulse was performed at E10.5 in mice and it
638 was observed that the number of BrdU+ POMC and
639 BrdU+ NPY neurons in the ARC decreased by 50%
640 from 4 weeks old to 12 weeks old lean mice suggesting
641 that half of the neurons are renewed post-natally. No
642 cell renewal was measured at later time points from 8 to
643 26 weeks old in the ARC. There was no difference in
644 the number of BrdU+ cells in the amygdala at any time
645 point, suggesting that cell renewal during adulthood may
646 be restricted to specific brain areas (McNay et al.,
647 2012). By comparison, DIO mice display a lower amount
648 of newly born cells compared to chow-fed mice from 16 to
649 20 weeks of age, suggesting that nutritional and/or hor-
650 monal status affect neurogenesis in the ARC (McNay
651 et al., 2012). Further experiments uncovered that DIO
652 inhibits the differentiation of stem cells into proliferative
653 progenitor-like cells and increases apoptosis. Neurogene-
654 sis in adult ob/ob mice was even more reduced than in
655 DIO mice confirming the crucial role of leptin in neuro-
656 genic processes at adulthood (McNay et al., 2012). In
657 the hippocampus, chronic leptin administration in adult
658 lean mice increased cell proliferation without altering dif-
659 ferentiation or survival rate of these newly proliferated
660 cells; these leptin-induced mechanisms could be involved
661 the improvement of spatial memory and learning that has
662 been shown after leptin injection (Farr et al., 2006;
663 Oomura et al., 2006). More recently, the administration
664 of leptin in the lateral ventricle of adult ob/ob mice
665 enhanced spatial memory when combined with mild-
666 exercise and anti-oxidative interventions, supporting the
667 notion that leptin contributes to hippocampus-based plas-
668 ticity (Yook et al., 2019). In vivo and in vitro mechanistic
669 studies by Garza et al. showed that leptin enhanced adult
670 cell proliferation in the hippocampus by activating
671 pSTAT3 and Akt intracellular signaling pathways (Garza
672 et al., 2008). Whether this is also true in other brain areas
673 still needs to be uncovered.
674 Amylin also appears to contribute to neurogenesis in
675 the adult brain. In the AP, our group found that acute
676 and chronic amylin treatment upregulates genes, such
677 as NeuroD1, that are involved in cell proliferation and
678 neurogenesis (Liberini et al., 2016a). Amylin’s effect on
679 cell birth was explored in lean adult male rats injected with
680 BrdU for 1 week and concomitantly treated with amylin for
681 4 weeks. Amylin treatment increased the number of BrdU
682 + cells in the AP compared to control-treated rats, and
683 these cells were identified as neurons, suggesting that
684 amylin is able to increase neurogenesis in the AP of adult
685 rats (Liberini et al., 2016a). Investigations into amylin’s
686 role in neurodegenerative diseases, such Alzheimer’s,
687 has shown that lower amylin plasma levels have been
688 detected in patients presenting mild cognitive impairment
689 and Alzheimer’s symptoms. The chronic injection of
690 senescence-accelerated prone mouse with pramlintide,
691 an amylin analog, improved memory and cognition and
692 increased the synaptic marker synapsin 1, suggesting
693neuroprotective effects of amylin (Adler et al., 2014). Sur-
694prisingly, in a rat H19-7 HN cell line, pharmacological con-
695centrations of amylin decreased cell proliferation while
696leptin had the opposite effect. Furthermore, amylin
697decreased cell differentiation into neurons while leptin
698promoted it. The co-treatment of these cells with amylin
699and leptin had no effect on cell proliferation suggesting
700that amylin inhibited leptin cell-induced proliferation and
701differentiation (Moon et al., 2013). This discrepancy with
702previous studies could be explained by the fact that Moon
703et al. used human amylin which can aggregate and pro-
704mote cell death. The in vivo interaction between amylin
705and leptin on cell proliferation and neurogenic processes
706has not been assessed yet during adulthood. Whether
707this could be of interest in the treatment of obesity or neu-
708rodegenerative diseases remains to be determined.
709Neuronal pathway development during the neonatal
710period
711Following cell birth, differentiation and migration, neurons
712develop connections to other neurons located in the same
713or in other nuclei. This phenomenon takes place during
714the last week of gestation and during the first 2 weeks
715of life for a rodent (Bouret, 2017; Bouret and Simerly,
7162006), and during the first 6 months of life in humans
717(Stiles and Jernigan, 2010). These axonal projections
718develop throughout the brain and since amylin and lep-
719tin’s primary sites of action are the AP and the ARC,
720respectively, these specific brain nuclei will be examined
721here.
722Neuronal pathway development from ARC to PVN.
723Axonal outgrowth from the two major neuronal
724populations in the ARC, AgRP/NPY neurons and POMC
725neurons, has been extensively studied. These neurons
726project mainly to the PVN, LH and the DMN (Baker and
727Herkenham, 1995; Broberger et al., 1998). Grove et al.
728(2003) and Nilsson et al. (2005) have shown that axonal
729projections from AgRP/NPY and POMC neurons develop
730during the second postnatal week in rats and mice. While
731immunohistochemistry is commonly used to detect pep-
732tides travelling along the axons, the fluorescent tracer
733DiI, is a robust method for visualizing developing neuronal
734pathways, independent of neuronal or axonal peptide syn-
735thesis, which may change over the period of investigation.
736Using the DiI technique, it has been shown that ARC?
737PVN and ARC? DMN axonal projection reflects the
738development pattern of AgRP/NPY innervation (Bouret
739et al., 2004a). At P6, ARC axons projects to the DMN
740and by P8 they send input to the PVN and finally by
741P12 to the LH (Bouret and Simerly, 2004).
742Interestingly, leptin blood level surges from P7 to P12
743(Ahima et al., 1998) and this peak coincides with the axo-
744nal outgrowth that takes place in the ARC. Leptin-
745deficient ob/ob mice present a strong disruption in
746ARC? PVN and ARC? LH projections that are restored
747if the mice are injected twice daily with leptin during the
748first two weeks of neonatal life, but not when injected in
749adult mice (Bouret et al., 2004b); the same disruption
750was also found in db/db mice (Bouret et al., 2004b). Using
751ARC explants from neonatal mice, it was shown that the
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752 activation of pSTAT3 and pERK pathways by leptin
753 seems to be necessary to promote fiber outgrowth.
754 Hence, leptin presents a trophic action that is necessary
755 for the development of the mediobasal hypothalamus,
756 while it assumes its role in the regulation of energy home-
757 ostasis after these pathways have completed their devel-
758 opment (Ahima and Hileman, 2000; Bouret et al., 2004b;
759 Mistry et al., 1999; Steppan and Swick, 1999). Nonethe-
760 less, it needs to be mentioned that naı̈ve adult ob/ob
761 mice, with disrupted ARC projections, are still responsive
762 to leptin injections, and reduce eating as observed in con-
763 trol lean animals (Mistry et al., 1997).
764 The model of selectively bred DIO and DR rats reflect
765 the polygenic abnormalities of human obesity (Levin et al.,
766 2008). Chow-fed DIO rats are larger but not fatter than DR
767 rats, but on high energy diet, DIO rats gain more weight
768 and eat more than DR rats (Levin and Dunn-Meynell,
769 2002; Levin et al., 1997). DIO rats have reduced leptin
770 signaling as early as P7 (Patterson et al., 2010;
771 Johnson et al., 2016), and this defect is mostly present
772 in POMC neurons (Johnson et al., 2016). Furthermore,
773 DIO rat neonates have defective ARC? PVN projections
774 that persist into adulthood (Bouret et al., 2008); this defect
775 affects the outgrowth of both POMC and AgRP/NPY
776 fibers. When ARC explant form DIO and DR P10 rats
777 are exposed to leptin, only DR explants respond to the
778 trophic action of leptin (Bouret et al., 2008), whereas
779 DIO explants are insensitive due to their inherent leptin
780 resistance that is already present at P10 (Johnson
781 et al., 2016).
782 Contrary to leptin, baseline blood amylin
783 concentration does not seem to fluctuate postnatally
784 (Abegg et al., 2017). Since amylin modulates leptin sig-
785 naling, amylin’s trophic action was also examined in the
786 mediobasal hypothalamus. RAMP 1/3 KO mice, which
787 present deficient amylin signaling, showed a decrease in
788 ARC? PVN POMC and AgRP/NPY fibers projections,
789 whereas amylin KO mice only presented a decrease in
790 a-MSH fibers in the PVN (Lutz et al., 2018). The depletion
791 of CTR in rat neonates (P4) also only decreased the den-
792 sity of a-MSH fibers in the PVN. Since in adult animals,
793 amylin is able to activate microglial IL-6 production, which
794 then acts on its neuronal gp130 receptor to enhance
795 leptin-induced pSTAT3 (Le Foll et al., 2015), IL6 KO mice
796 were examined and surprisingly, these mice only pre-
797 sented a decrease in AgRP fiber density in the PVN
798 (Johnson et al., 2016). Our current hypothesis is that dur-
799 ing the neonatal stage, amylin acts as a neurotrophic fac-
800 tor directly on POMC neurons during the first two weeks
801 of life to enhance leptin-induced development of fiber pro-
802 jections to the PVN, while amylin may acts indirectly on
803 NPY neurons through IL-6 (Levin and Lutz, 2017). The
804 treatment of DIO neonates with amylin from P0 to P16
805 restored their a-MSH and AgRP/NPY fiber development
806 to the PVN and increased leptin signaling at P21. How-
807 ever, despite this pathway correction, amylin treatment
808 during the neonatal period did not protect adult DIO rats
809 against weight gain and leptin resistance (Johnson
810 et al., 2016). In conclusion, amylin and leptin seem to play
811 an important role in the development of the mediobasal
812hypothalamus, which is critical for the control of energy
813homeostasis.
814Neuronal pathway development from AP to NTS. To
815assess amylin’s neurotrophic properties in the AP, the
816fluorescent tracer DiI was implanted into the AP of
817amylin KO mice at P10 and P60 in order to measure the
818neurite outgrowth from the AP to the NTS (Abegg et al.,
8192017). At both ages, the neurite outgrowth was decreased
820in amylin KO mice, demonstrating that endogenous amy-
821lin seems to be necessary for the promotion of axonal
822pathway development from AP? NTS during the early
823postnatal period, and that this effect persists into adult-
824hood. Similarly, ob/ob mice presented a decrease in fiber
825projections from AP? NTS at P14, but unlike amylin KO
826mice, this effect did not persist until adulthood. As dis-
827cussed above, it has been recently shown that amylin is
828also produced by neurons in the brain (Li et al., 2015),
829and whether brain-derived amylin influences these neu-
830rotrophic processes also needs to be assessed.
831The data and literature reviewed above provide
832evidence that leptin and amylin, metabolic hormones
833controlling food intake and body weight, are also key
834players supporting neural and physiological adaptations
835that occur during pregnancy, lactation, and postnatal
836development. We have also presented several
837unanswered questions related to how these hormones
838influence each other during these specific phases of life.
839For instance, the precise function and regulation of
840centrally produced amylin, notably during lactation but
841also in non-lactating females and males, remains
842unknown. What is amylin really doing in the brain? Does
843it regulate the increased caloric need to support
844lactation or is its function unrelated to metabolic control?
845Could neurons in fact be the source of amylin that
846sensitizes leptin-responsive neurons in hypothalamus?
847Does central amylin influence the development of leptin-
848regulated neuronal pathways? Is the interaction of
849amylin and leptin always dependent on amylin-induced
850IL-6 levels, or might other mechanisms underlie this
851relationship during phases of development or related to
852pregnancy and lactation? The answers to these key
853questions will provide a better understanding of which
854biological processes amylin and leptin co-regulate
855during these different developmental phases, and
856whether alteration of these processes contributes to the
857development of or protection from obesity.
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